![Harpreet Singh-Jasuja](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Harpreet Singh-Jasuja
Fondateur chez
IMMATICS N.V.
Fortune : 3 M $ au 31/05/2026
Profil
Dr. Harpreet Singh-Jasuja is a President & Chief Executive Officer at Immatics US, Inc., a Chief Executive Officer at Immatics Biotechnologies GmbH and a Chief Executive Officer, Executive Director & MD at Immatics NV.
He is on the Board of Directors at Immatics NV.
He received his undergraduate degree from Eberhard Karls Universität Tübingen and a doctorate degree from Eberhard Karls Universität Tübingen.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IMMATICS N.V. 0,16% | 18/03/2026 | 217 241 ( 0,16% ) | 3 M $ | 31/05/2026 |
Postes actifs de Harpreet Singh-Jasuja
| Sociétés | Poste | Début |
|---|---|---|
| IMMATICS N.V. | Fondateur | 01/01/2000 |
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH BiotechnologyHealth Technology Operates as a bio technology company that develops and delivers T cell redirecting immunotherapies for treatment of cancer | Directeur Général | 01/01/2000 |
Immatics US, Inc.
 Immatics US, Inc. BiotechnologyHealth Technology Develops adoptive cell therapies for treatment of cancer | Directeur Général | 01/06/2015 |
Formation de Harpreet Singh-Jasuja
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
20
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Immatics Biotechnologies GmbH
Immatics Biotechnologies GmbH BiotechnologyHealth Technology Operates as a bio technology company that develops and delivers T cell redirecting immunotherapies for treatment of cancer | Health Technology |
Eberhard Karls Universität Tübingen
 Eberhard Karls Universität Tübingen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immatics US, Inc.
Immatics US, Inc. BiotechnologyHealth Technology Develops adoptive cell therapies for treatment of cancer | Health Technology |
Immatics NV
 Immatics NV Pharmaceuticals: MajorHealth Technology Engages in developing immunotherapies for cancer treatments | Health Technology |
